Answers are grounded in this paper and cite their sources.
Xerostomia is a severe side effect of radiation therapy in head and neck cancer patients. To date, no satisfactory treatment option has been established. Because mesenchymal stem cells (MSCs) have been identified as a potential treatment modality, we aimed to evaluate stem cell distribution following intravenous and intraglandular injections using a surgical model of salivary gland damage and to analyse the effects of MSC injections on the recruitment of immune cells. The submandibular gland ducts of rats were surgically ligated. Syngeneic adult MSCs were isolated, immortalised by simian virus 40 (SV40) large T antigen and characterized by flow cytometry. MSCs were injected intravenously and intraglandularly. After 1, 3 and 7 days, the organs of interest were analysed for stem cell recruitment. Inflammation was analysed by immunohistochemical staining. We were able to demonstrate that, after intravenous injection, MSCs were recruited to normal and damaged submandibular glands on days 1, 3 and 7. Unexpectedly, stem cells were recruited to ligated and non-ligated glands in a comparable manner. After intraglandular injection of MSCs into ligated glands, the presence of MSCs, leucocytes and macrophages was enhanced, compared to intravenous injection of stem cells. Our data suggest that injected MSCs were retained within the inflamed glands, could become activated and subsequently recruited leucocytes to the sites of tissue damage. Stem cells injected into damaged salivary glands help promote tissue healing, according to a study in rats. A team led by Nicole Rotter from the Ulm University Medical Center, Germany, surgically injured submandibular salivary glands in rats. The researchers then injected mesenchymal stem cells (MSCs) derived from a rat bone marrow cell line into the tail veins. They observed a migration of the stem cells into both healthy and damaged salivary glands. Rotter and her colleagues also injected the MSCs directly into the rats' salivary glands, where the stem cells recruited immune cells, including leukocytes and macrophages, to the site of injury. MSC therapy thus promotes beneficial immune responses and could help people overcome the dry mouth side effects that result from salivary gland damage associated with radiation administered for head and neck cancer.
No takes yet. Share an insight, caveat, or question.
Schwarz et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: